이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

EXtubation 관련 합병증 - EXTUBE 연구(EXTUBE) (EXTUBE)

2026년 10월 19일 업데이트: University Health Network, Toronto

EXtubation 관련 합병증 - 수술실 및 중환자실의 영향과 모범 사례를 이해하기 위한 국제 관찰 연구 - EXTUBE 연구

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

연구 개요

상태

모병

정황

상세 설명

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

연구 유형

관찰

등록 (추정된)

3000

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

  • 이름: Shayan Wasim, MPH, BSc
  • 전화번호: 4221 +1 416 340 4800
  • 이메일: shayan.wasim@uhn.ca

연구 장소

      • Auckland, 뉴질랜드, 1023
        • 완전한
        • Auckland City Hospital
      • Invercargill, 뉴질랜드, 9812
        • 완전한
        • Southland Hospital
      • Rotorua, 뉴질랜드, 3010
        • 완전한
        • Rotorua Hospital
    • Arizona
      • Tucson, Arizona, 미국, 85724-5114
        • 완전한
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, 미국, 72205
        • 완전한
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, 미국, 32608
        • 완전한
        • University of Florida
    • Illinois
      • Chicago, Illinois, 미국, 60637
        • 완전한
        • The University of Chicago
    • Oregon
      • Portland, Oregon, 미국, 97239
        • 완전한
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, 미국, 77030
        • 완전한
        • The University of Texas Health Science Center
      • Singapore, 싱가포르, 308433
        • 완전한
        • Tan Tock Seng Hospital
      • Castlebar, 아일랜드, F23 H529
        • 완전한
        • Mayo University Hospital
      • Cork, 아일랜드, T12 DFK4
        • 완전한
        • Cork University Hospital
      • Dublin, 아일랜드, D07 R2WY
        • 완전한
        • Mater Misericordiae University Hospital
      • Galway, 아일랜드, H91 YR71
        • 완전한
        • Galway University Hospitals
      • Waterford, 아일랜드, X91 ER8E
        • 아직 모집하지 않음
        • University Hospital Waterford
        • 연락하다:
        • 연락하다:
        • 수석 연구원:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • 부수사관:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Bath, 영국, BA1 3NG
        • 완전한
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, 영국, NE7 7DN
        • 완전한
        • Freeman Hospital
    • British Columbia
      • Surrey, British Columbia, 캐나다, V3V 1Z2
        • 완전한
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, 캐나다, E1C 4B7
        • 완전한
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, 캐나다, M4N 3M5
        • 완전한
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, 캐나다, L2S 0A9
        • 완전한
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, 캐나다, M5B 1W8
        • 완전한
        • St. Michael's Hospital
      • Toronto, Ontario, 캐나다, M5G 1X5
        • 완전한
        • Mount Sinai Hospital
      • Toronto, Ontario, 캐나다, M5G 2C4
        • 모병
        • University Health Network - Toronto General Hospital
        • 연락하다:
        • 수석 연구원:
          • Matteo Parotto, MD, PhD
        • 연락하다:
        • 부수사관:
          • Alicia Grassi, MD
      • Toronto, Ontario, 캐나다, M5T 2S8
        • 완전한
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, 캐나다, H2X 0C1
        • 완전한
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Piedecuesta, 콜롬비아
        • 완전한
        • Hospital Internacional de Colombia
      • Kuwait City, 쿠웨이트
        • 완전한
        • Amiri Hospital
    • New South Wales
      • Sydney, New South Wales, 호주, 2065
        • 완전한
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, 호주, 3135
        • 완전한
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, 호주, 3156
        • 완전한
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, 호주, 3076
        • 완전한
        • The Northern Hospital
      • Melbourne, Victoria, 호주, 3128
        • 완전한
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, 호주, 3084
        • 완전한
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, 호주, 3079
        • 완전한
        • Austin Health - Heidelberg Repatriation Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

확률 샘플

연구 인구

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

설명

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
기간: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

2차 결과 측정

결과 측정
측정값 설명
기간
Difficult airway and complications related to airway management if reintubation is required
기간: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
기간: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
기간: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
기간: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
기간: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
기간: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
기간: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
기간: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
기간: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
기간: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
기간: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
기간: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Matteo Parotto, MD, PhD, UHN

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 4월 14일

기본 완료 (추정된)

2027년 12월 1일

연구 완료 (추정된)

2027년 12월 1일

연구 등록 날짜

최초 제출

2024년 3월 28일

QC 기준을 충족하는 최초 제출

2024년 6월 3일

처음 게시됨 (실제)

2024년 6월 5일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 22일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 10월 19일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 24-5811
  • 4850 (기타 식별자: Clinical Trials Ontario - CTO)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .